Sallyso is a pharmaceutical excipient based on Croscarmellose Sodium (a cross-linked polymer of carboxymethylcellulose sodium) used as a superdisintegrant in oral solid dosage (OSD) forms such as tablets and capsules.

Croscarmellose Sodium excipient is designed to promote rapid tablet disintegration and faster drug dissolution, supporting improved bioavailability and efficient drug release in oral formulations.

Sallyso excipient functions as an effective disintegrant and superdisintegrant that supports fast disintegration, improved dissolution, enhanced bioavailability, and consistent formulation performance while maintaining good compression and flow properties even at low usage levels of 0.5% to 3.0%.

Due to its non-hygroscopic nature, chemical inertness, and good mouthfeel properties, Mannitol excipient supports stable pharmaceutical formulations, consistent processing, and enhanced patient compliance.

Croscarmellose Sodium excipient is primarily used in oral dosage forms such as tablets, capsules, and orally disintegrating tablets (ODTs) where rapid disintegration and dissolution are required.

Sallyso (Croscarmellose Sodium excipient) is suitable for wet granulation, dry granulation, and direct compression processes, making it a versatile excipient for a wide range of pharmaceutical and nutraceutical oral formulations.

Croscarmellose Sodium excipient from Gangwal Healthcare is manufactured under stringent WHO-GMP and complies with major pharmacopeial standards including USP-NF, BP, IP, and EP.

This pharmaceutical excipient is supported with regulatory documentation and certifications such as DMF, EXCiPAT, Kosher, and Halal, ensuring reliable quality and regulatory compliance.